About Alergo-Med. Specjalistyczna Przychodnia Lekarska Sp. z o. o.
"Przychodnia świadczy usługi w ramach umowy z NFZ oraz odpłatnie. Oferujemy konsultacje lekarskie: alergologiczne dla dzieci i dorosłych, pulmonologiczne, pediatryczne, dermatologiczne, chirurgiczne dla dzieci i dorosłych, proktologiczne, ortopedyczne, laryngologiczne, kardiologiczne, endokrynologiczne, diabetologiczne, gastroenterologiczne, logopedyczne oraz internistyczne. Wykonujemy badania endoskopowe (kolonoskopia, gastroskopia), zabiegi chirurgiczne ambulatoryjne, testy alergiczne, szczepienia ochronne oraz badania USG dla dzieci i dorosłych."
Clinical Trials at Alergo-Med. Specjalistyczna Przychodnia Lekarska Sp. z o. o.
During the past decade, Alergo-Med. Specjalistyczna Przychodnia Lekarska Sp. z o. o. conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 7 clinical trials were completed, i.e. on
average, 38.9% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 5 clinical trials were completed. i.e. 55.6%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Alergo-Med. Specjalistyczna Przychodnia Lekarska Sp. z o. o." #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "HAL Allergy" with 3 trials
sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Anergis"
with 3 trials sponsored. Other sponsors include 8 different institutions and
companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Alergo-Med. Specjalistyczna Przychodnia Lekarska Sp. z o. o."
#1 collaborator was "Dermira, Inc." with 3 trials as a collaborator, "Ergomed" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator, "Labor Dr. Spranger (Central lab)" with 1 trials as a collaborator and "Laboratorios LETI SL (Study Medication)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 8 trials.
Clinical Trials Conditions at Alergo-Med. Specjalistyczna Przychodnia Lekarska Sp. z o. o.
According to Clinical.Site data, the most researched conditions in "Alergo-Med. Specjalistyczna Przychodnia Lekarska Sp. z o. o." are
"Atopic Dermatitis" (6 trials), "Allergic Rhinitis" (4 trials), "Allergic Rhinoconjunctivitis" (3 trials), "Asthma" (3 trials) and "Skin Diseases" (3 trials). Many other conditions were trialed in "Alergo-Med. Specjalistyczna Przychodnia Lekarska Sp. z o. o." in a lesser frequency.
Clinical Trials Intervention Types at Alergo-Med. Specjalistyczna Przychodnia Lekarska Sp. z o. o.
Most popular intervention types in "Alergo-Med. Specjalistyczna Przychodnia Lekarska Sp. z o. o." are "Drug" (16 trials), "Biological" (7 trials) and "Other" (5 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (13 trials), "Lebrikizumab" (5 trials), "Orismilast modified release tablets" (2 trials), "Abrocitinib 100 mg" (1 trials) and "Abrocitinib 200 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Alergo-Med. Specjalistyczna Przychodnia Lekarska Sp. z o. o.
The vast majority of trials in "Alergo-Med. Specjalistyczna Przychodnia Lekarska Sp. z o. o." are
27 trials for "All" genders.
Clinical Trials Status at Alergo-Med. Specjalistyczna Przychodnia Lekarska Sp. z o. o.
Currently, there are NaN active trials in "Alergo-Med. Specjalistyczna Przychodnia Lekarska Sp. z o. o.".
undefined are not yet recruiting,
2 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 21 completed trials in Alergo-Med. Specjalistyczna Przychodnia Lekarska Sp. z o. o.,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Alergo-Med. Specjalistyczna Przychodnia Lekarska Sp. z o. o., 1 "Phase 1"
clinical trials were conducted, 11 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 3 trials that are defined as “Not Applicable".